Lv4
590 积分 2024-06-17 加入
Efficacy and safety of topical WBI-1001 in patients with mild to severe atopic dermatitis: results from a 12-week, multicentre, randomized, placebo-controlled double-blind trial
3天前
已完结
A multi-center, double-blind, randomized, placebo- and positive-controlled phase II clinical study of benvitimod for the treatment of atopic dermatitis
3天前
已完结
A phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of atopic dermatitis
3天前
已完结
A phase 2, randomized, double‐blind, vehicle‐controlled trial of tapinarof cream in Japanese pediatric patients with atopic dermatitis
3天前
已完结
The Adverse Effects Profile of Teprotumumab
1个月前
已完结
Teprotumumab, an IGF-1R Blocking Monoclonal Antibody Inhibits TSH and IGF-1 Action in Fibrocytes
1个月前
已完结
Efficacy and safety of crisaborole ointment in Chinese and Japanese patients aged ≥2 years with mild‐to‐moderate atopic dermatitis
1个月前
已完结
Crisaborole Ointment Provides Early Relief of Pruritus in Two Phase 3 Clinical Trials in Patients With Mild or Moderate Atopic Dermatitis
1个月前
已完结
Pharmacokinetic Profile, Safety, and Tolerability of Crisaborole Topical Ointment, 2% in Adolescents with Atopic Dermatitis: An Open‐Label Phase 2a Study
1个月前
已完结
皖公网安备34019202002308
